ARISTA™ COVID-19 Nucleic Acid Detection Kit
ACCURATE, FAST, AND PORTABLE
“Performance studies on the ARISTA™ COVID-19 Nucleic Acid Detection Kit indicated an overall agreement of 99% when compared to benchmark RT-PCR, the gold standard for COVID-19 diagnostic testing which is often associated with sophisticated lab machines, complex workflows, slow turnaround time, and high cost.”
The ARISTA™ COVID-19 Nucleic Acid Detection Kit uses RT-RAA (recombinase-aided amplification) assay with the portable G30 or GT120S isothermal machine deployed onsite to produce highly accurate results within 90 minutes at around 50% of the cost of PCR testing. It is an ideal frontline solution where accuracy and speed are critical.
CONVENIENT RECORD MANAGEMENT
The ARISTA™ COVID-19 Nucleic Acid Detection Kit is compatible with the Viva Life App, allowing individuals to securely store their test records on their phone and generate a digital certificate whenever required, and when paired with the Viva Life Enterprise Account, these test results can be synced to an organization dashboard that they are associated with – such as their workplace or school – facilitating safer spaces for everyone.
ARISTA™ COVID-19 Nucleic Acid Detection Kit is a reverse transcription recombinase-aided amplification (RT-RAA) in-vitro diagnostic test intended for the detection of nucleic acid from the SARS-CoV-2 virus in human oropharyngeal swab and nasopharyngeal swab specimens collected from individuals suspected of COVID-19 by their healthcare provider. It uses lateral flow dipsticks to detect amplified product.
Performance studies conducted on the ARISTA™ COVID-19 Nucleic Acid Detection Kit indicated a sensitivity of 96.8% and a specificity of 100% with overall agreement to PCR of 98.7%.
The ARISTA™ COVID-19 Nucleic Acid Detection Kit complies with European In-Vitro Diagnostic Devices Directive 98/79/EC.
